Navigation Links
Daiichi Sankyo/Lilly Respond to ACCF/AHA Clinical Alert on Antiplatelet Therapy
Date:6/28/2010

INDIANAPOLIS and PARSIPPANY, N.J., June 28 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. and Eli Lilly and Company appreciate the availability of a "Clinical Alert" from the American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) in response to the FDA's Boxed Warning about Plavix® (clopidogrel), and commend the leading cardiovascular medical societies for providing perspective on the importance of genetic make-up and the variability in response of certain oral anti-platelet (OAP) therapy for patients with acute coronary syndrome (ACS) who are managed with angioplasty and stenting (known as PCI). This statement is being issued in light of references in the Clinical Alert to the companies' co-developed product, Effient® (prasugrel).

"We believe the medical community will find the clinical alert from the leading cardiovascular medical societies on this important issue both timely and welcome," said LeRoy LeNarz, MD, senior medical director, Cardiovascular, Lilly USA, LLC. "It is important for physicians – and patients – to recognize the potential impact of a variety of factors, including genetics, on clopidogrel response, as well as the prevalence of these genetic variations in the general population, and we look forward to working with physicians as they identify ways to help manage these issues while the science continues to evolve."

Common Genetic Variations:  No Impact on Effient  

Unlike clopidogrel, there is no relevant effect of genetic variation in CYP2C19 on the pharmacokinetics of the active metabolite of Effient or its inhibition of platelet aggregation.  Genetic variation in CYP2B6, CYP2C9 or CYP3A5 also has no impact on its active metabolite or i
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Daiichi Sankyo Co, Ltd. Joins the National Cherry Blossom Festival in Washington D.C. as Centennial Celebration Committee Co-Chair
2. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
3. Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
4. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
5. Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
6. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
7. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
8. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
9. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
10. Coalition for Pulmonary Fibrosis Responds to News of Further Review of Pirfenidone By FDA
11. New Science Education Program Responds to Presidents Call to Help Young People Excel in Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... its catalogue: Global Feminine Hygiene Products Industry ... report analyzes the worldwide markets for Feminine Hygiene Products ... Pads/Towels, Tampons, Panty liners, and Others. The report provides ... , Japan , ...
(Date:8/20/2014)... 2014 Reportlinker.com announces that a new ... The Market for Medical Devices in ... European, Middle Eastern and African markets represent significant ... of its coverage, this study: The Market for ... medical device markets and estimates markets for specific ...
(Date:8/20/2014)... DIEGO , Aug. 20, 2014 Trovagene, ... diagnostics, announced today that results from two clinical studies ... conference for the Company,s urine-based diagnostic test for the ... The IPV conference is scheduled to take place in ... to 25 th . Additionally, a new U.S. ...
Breaking Medicine Technology:Global Feminine Hygiene Products Industry 2Global Feminine Hygiene Products Industry 3Global Feminine Hygiene Products Industry 4Global Feminine Hygiene Products Industry 5Global Feminine Hygiene Products Industry 6Global Feminine Hygiene Products Industry 7Global Feminine Hygiene Products Industry 8Global Feminine Hygiene Products Industry 9Global Feminine Hygiene Products Industry 10Global Feminine Hygiene Products Industry 11Global Feminine Hygiene Products Industry 12Global Feminine Hygiene Products Industry 13Global Feminine Hygiene Products Industry 14Global Feminine Hygiene Products Industry 15Global Feminine Hygiene Products Industry 16Global Feminine Hygiene Products Industry 17Global Feminine Hygiene Products Industry 18Global Feminine Hygiene Products Industry 19Global Feminine Hygiene Products Industry 20Global Feminine Hygiene Products Industry 21Global Feminine Hygiene Products Industry 22Global Feminine Hygiene Products Industry 23Global Feminine Hygiene Products Industry 24Global Feminine Hygiene Products Industry 25Global Feminine Hygiene Products Industry 26The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3
... Arnold & Itkin LLP has filed five ... on claims that many of the companies, defective devices ... the attorneys at Arnold & Itkin are ... shoulder surgery. The pumps utilize a catheter to deliver continuous doses ...
... , BEDFORD, Mass., Nov. 11 Hologic, Inc. (Nasdaq: ... at the NASDAQ OMX 23rd Investor Program in London on ... parties are invited to listen to a live audio webcast ... company,s website at www.hologic.com/investor . An archive ...
Cached Medicine Technology:Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps 2Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps 3
(Date:8/20/2014)... New York, NY (PRWEB) August 20, 2014 ... Open Tennis Championship tickets in NYC. In just a ... USTA Billie Jean King Tennis Center. The event was originally founded ... the 2013 event, Rafael Nadal was forced to withdrawal from the ... of the 2014 women’s tournament and will return to New York ...
(Date:8/20/2014)... Line: A study in Australia examined patient and ... (a marker of tumor cell growth) in an ... cancer in patients. , Author: ... Victoria, Australia, and colleagues. , Background: The ... cell division) has been connected with prognosis and ...
(Date:8/20/2014)... Opinion: The time to deploy Ebola vaccines is now, ... vaccines is now, according to a commentary being published ... Medicine . The authors from Yale School of ... geographic dissemination of the current Ebola outbreak represent a ... under current efforts. Several Ebola vaccines have been developed ...
(Date:8/20/2014)... Aug. 20, 2014 (HealthDay News) -- Loss of brain ... explain why many seniors have trouble falling and staying ... sleep disruption can be especially severe and often results ... The investigators analyzed data from the Rush Memory ... enrolled at age 65 and are being followed until ...
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 The ... firm Perkins Eastman is pleased to announce ... services in China and the surrounding ... Principal Richard Sprow AIA has relocated to ... 40-year career in healthcare planning and design and to ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:News from Annals of Internal Medicine 2Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3
... of it kind to establish a link between sleep and ... have higher insulin resistance, and a harder time controlling the ... Diabetes Care , suggest that poor sleep may contribute ... quality in people with diabetes was associated with worse control ...
... By Serena Gordon HealthDay Reporter , MONDAY, ... supplements and teas for infants is a surprisingly common practice, ... not be safe for babies. The study, conducted ... 10 percent of babies are given botanical supplements or teas ...
... News) -- Infants who aren,t breast-fed may experience long-term health ... body composition (fat mass vs. lean body mass) and blood ... for the first four months of life, while infants in ... formula: a lower-protein formula with 1.8 grams (g) of protein ...
... DENVER, CO, MAY 2, 2011 Two scientists who ... been chosen to receive the 2011 March of Dimes ... OBE, DSc, FRS, professor of Human Genetics, Southampton University ... Laboratory, Salisbury, England and David C. Page, MD, director, ...
... ROCHESTER, Minn. -- By all counts, the 54-year-old man ... Minnesota would likely have died. He,d suffered a heart ... and a series of shocks with a defibrillator, the ... this particular instance of cardiac arrest ( http://www.mayoclinic.org/heart-attack/ ), ...
... May 2 (HealthDay News) -- Obese pregnant women may have ... new research suggests. Researchers tested the blood of 30 ... and had a body-mass index (BMI) of more than 30 ... of 20 to 25. Obese women had fewer immune ...
Cached Medicine News:Health News:Insomnia linked to high insulin resistance in diabetics 2Health News:Study Questions Giving Babies Botanical Supplements, Teas 2Health News:Study Questions Giving Babies Botanical Supplements, Teas 3Health News:Breast-feeding May Influence Long-Term Health: Study 2Health News:Mayo Clinic CPR efforts successful on man with no pulse for 96 minutes 2
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... The Self-Cath Closed System is a ... method for safe, simple catheterization designed ... tract infections. It includes a ... The new EasyOff tear tab makes ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
Medicine Products: